4’-DMA-7,8-DHF ( Eutropoflavin ) 10mg / 60 capsule
4’-DMA-7,8-DHF ( Eutropoflavin ) 10mg / 60 capsule
Currently unavailable
NovaMeds
Illustrative packaging generated with AI. Choose your strength and pack below.
Lisdexamfetamine · Capsules
Lisdexamfetamine, marketed as Vyvanse in the US, Canada and Australia. A controlled drug.
Vyvanse is the brand name of lisdexamfetamine dimesylate in the United States, Canada and Australia. It is used for attention deficit hyperactivity disorder (ADHD) and, in some markets, for moderate to severe binge eating disorder in adults. It is a controlled drug supplied only under strict prescription rules.
Suitability and dosing are decided by a prescriber on the basis of the approved product information.
Lisdexamfetamine is inactive as taken. After absorption it is converted in the blood to dexamfetamine, which increases the activity of dopamine and noradrenaline in the brain. The gradual conversion gives an effect that lasts through the day with once-daily dosing.
It is used as part of a comprehensive treatment program that includes psychological, educational and social measures.1
Commonly reported side effects include:
Vyvanse is a prescription-only medicine. After your request, the partner pharmacy verifies whether and how supply is possible, for example through an existing prescription or an assessment by an independent doctor where permitted.
Yes. Lisdexamfetamine is a controlled drug and is supplied only under strict prescription rules, which differ between markets.
They contain the same active ingredient, lisdexamfetamine dimesylate, under brand names used in different markets. Presentations and authorized uses follow the product information of each market.
No. Payment is arranged individually with customer service once your request has been reviewed and can proceed.